Steven Smith

Don't Call the Top, Sell the Call

 

Giving Up Gains but Gaining a Cushion

A beneficial tradeoff of limiting your profit potential is that shorting calls can substantially raise your net sales price. In our example, the effective sale price is $55.80, $5.80 or 11.6% higher than the current market price of $50.

"One of the major misconceptions involved in selling naked options is the risk, when in fact it is no greater than being outright short the underlying," says Mike Schwartz, chief option strategist at Fahnestock's Oppenheimer division. Schwartz's statement echoes a general rule of thumb in options trading: Don't be naked options with more than 90 days remaining until expiration. "This allows one to take advantage of the fact that options are an eroding asset," he says. An option's time decay, as defined by theta, accelerates as the expiration date approaches.

Winning by Not Losing

This means that even if the shares of the underlying simply stall or rise slowly, the naked-call seller can still realize a maximum profit. The table below provides the profit and loss profile for our hypothetical example.


Shorting 500 Shares of XYZ at $50 vs. Shorting 5 July $55 calls
P/L Based on price of XYZ on July 18 expiration
Position $45 $50 $55 $60
Short 500 XYZ at $50 $2,500 0 ($2500) ($5000)
Short five XYZ July $55 calls at 80 cents each $400 $400 $400 ($4600)

As you can see, the risk/reward for extreme moves would favor an outright shorting of the underlying shares should there be a precipitous decline. The naked calls provide a nice means of generating a moderate profit even if XYZ climbs higher than the initial entry point.

Shorting Biotech

While shorting biotechnology stocks has proven hazardous to your portfolio's health recently, I think this group is a prime candidate for employing a short call strategy. Using the Biotech HOLDRs(BBH) Exchange Traded Fund, or ETF, as a proxy for the group, the sector has gained some 38% over the past three months.


BBH Has Had Healthy Run
But now it needs to rest?

But I think the recent reversal off resistance at the $130 level will mute upside momentum in the near term. On Tuesday afternoon, with BBH trading at $123, one could sell the July 130 call for $3. This gives an implied sale price of $133, or 8.1% higher than the current market price. The maximum profit of $300 per call contract shorted will be realized should BBH settle at any price below the $130 strike price on the July 18 expiration.

While many stocks might seem to be hitting overbought levels, the market always seems to have a way of pushing a little further and longer than appears rational. This is where having the price cushion created by selling options can be invaluable. But remember: Shorting calls naked should be used as a relatively short-term trading tool rather than establishing a fundamentally long-term bearish position.


If you're new to RealMoney, we hope you're enjoying our open house. If you're interested in sampling our premium content for a little longer, click here for information on a free trial.

>To order reprints of this article, click here: Reprints

Steven Smith writes regularly for TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. He was a seatholding member of the Chicago Board of Trade (CBOT) and the Chicago Board Options Exchange (CBOE) from May 1989 to August 1995. During that six-year period, he traded multiple markets for his own personal account and acted as an executing broker for third-party accounts. He invites you to send your feedback to Steve Smith.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet